Figure 1.
Flow-mediated vasodilation (A) and nitroglycerine-induced vasodilation (B) in patients with essential hypertension (EHT), patients with aldosterone-producing adenoma (APA), and patients with idiopathic hyperaldosteronism (IHA).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.